Overview

Neurotrophic Factors and Depression

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Study intended to determine if there are baseline differences in serum neurosteroid levels and neurotrophic factor (BDNF) levels in healthy controls vs unmedicated depressed subjects, and whether the levels of these change with antidepressant treatment. Study also intended to determine if baseline neurosteroid/ BDNF levels, and the change in these levels with =treatment, are correlated with clinical antidepressant response to escitalopram (Lexapro).
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Citalopram
Dexetimide